Plain-English translation of NCT04588168 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether advanced MRI scans (special imaging that shows detailed pictures of your bladder) can help doctors determine early on how well gemcitabine-cisplatin is working for muscle-invasive bladder cancer. Researchers want to see if these detailed scans taken before, during, and after can predict how your cancer will respond and help guide your treatment decisions. This could help doctors personalize care and potentially improve outcomes.
Currently, doctors don't have a reliable way to know early in treatment whether is working well for this type of bladder cancer. By developing this imaging approach, doctors hope to catch treatment success or failure sooner, so they can adjust your care plan if needed and avoid unnecessary surgery or ineffective .
You likely qualify if…
You likely don't qualify if…
You would start with an MRI scan to stage your cancer. Then you would receive three cycles of (each cycle lasting 21 days), with an MRI scan after each cycle to monitor how your cancer is responding. After completing , you would have surgery to remove your bladder and nearby lymph nodes. Your surgical samples would then be examined by pathologists as part of standard care. The main addition compared to standard treatment is the extra MRI scans during to help guide your care.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China